Senior woman header
Senior woman header
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.

Learn More
Senior woman header
Senior woman header
Senior man header

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.
Learn More

Introducing the Syn-One Test™ from CND Life Sciences

Offering physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy.

seal icon

CLIA-Certified Pathology Lab

test tube icon

Dedication to Science & Research

DNA icon

Patient-Focused Mission

microscope icon

Quality & Reliability at Our Core

Clarity and Confidence of Syn-One

Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.  

Learn More

Our Commitment to Patients

We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.

Learn more about what drives us.

Learn More

Read our perspectives on the industry, the field of neurodiagnostics, patient care, and other topics.

Insights
May 1, 2020

Why Diagnostic Testing Reliability Matters

Perhaps there has been no other time in the last century when the topic of…
Insights
April 30, 2020

Minimally Invasive, Maximally Important

Neurodegenerative diseases like Parkinson’s and dementias continue to represent some of the most significant threats…
Insights
April 30, 2020

The Journey of a Skin Biopsy for the Syn-One Test™

Have you heard about the Syn-One Test™ from CND Life Sciences to help diagnose a…

Check out press releases, news alerts and coverage of CND happenings.

In the News
August 31, 2020

CND Founders’ Research in the New York Times

Drs. Christopher Gibbons and Roy Freeman--two of the founders of CND Life Sciences who also…
News Release
May 1, 2020

Mitsubishi Tanabe Pharma America Sponsors CND Life Sciences’ Study

CND will use its novel cutaneous neurodiagnostics platform to detect and measure changes in TDP-43…
News Release
April 2, 2020

CND Life Sciences Forms to Advance Diagnostic and Therapeutic Solutions

Company launches the Syn-One Test™ as the first commercially available skin-based test to help physicians…
CND CASE STUDIES

For Clinicians: Request a Syn-One Test™ Kit

The Syn-One Test provides objective pathological evidence to aid in the diagnosis of a synucleinopathy. Simply collect three small punch skin biopsies from your patient, send them to our CLIA-certified lab, and CND Life Sciences will provide important visual insights to support a diagnosis. If you are a clinician, click below to order a Syn-One Test Biopsy Kit.

Order a Kit